Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for relieving side reactions of targeted therapy and assisting in treatment of lung cancer

An adjuvant therapy and targeted therapy technology, applied in the medical field, can solve the problems of insensitivity of tumor targeted therapy, unsatisfactory effect of lung cancer, interstitial pneumonia, etc., to inhibit the growth of cancer cells, enhance the immune function, The effect of reducing side effects

Inactive Publication Date: 2018-04-06
SHANDONG UNIV QILU HOSPITAL
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The purpose of the present invention is to provide a drug for alleviating the side effects of targeted therapy and adjuvant therapy for lung cancer, aiming at solving the unsatisfactory effects of current targeted therapy drugs for lung cancer, some tumors are not sensitive to targeted therapy, and have side effects such as interstitial pneumonia. , the problem that some patients cannot tolerate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug for relieving side reactions of targeted therapy and assisting in treatment of lung cancer

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0031] Such as figure 1 As shown, the preparation method of the medicine for alleviating side effects of targeted therapy and adjuvant treatment of lung cancer provided by the implementation of the present invention comprises the following steps:

[0032] S101: Weigh 20-50 parts of ganoderma lucidum, 20-50 parts of ginseng, 30-60 parts of peagrass, 40-50 parts of sweet rhinoceros, 25-50 parts of Zhuling grass, and 30 parts of fennel by weight. 40 servings of fenugreek, 30~40 servings of scallion, 20~40 servings of milky white fragrant green, 30~40 servings of wild rice stem, 25~35 servings of fenugreek, 20~30 servings of bellflower chrysanthemum, 20 servings of lice flower 20 to 25 parts of Rubus chinensis, 15 to 20 parts of licorice, 45 to 55 parts of raw astragalus, 45 to 55 parts of honeysuckle, 20 to 30 parts of Patrinia, 20 parts of Trichosanthes ~30 servings, 10~20 servings of Scutellaria baicalensis, 10~20 servings of sweet almonds, 10~20 servings of Tinglizi, 5~15 ser...

Embodiment

[0037] According to clinical symptoms, signs and imaging examinations, one of the following conditions can be used as a clinical diagnosis:

[0038] 1. Chest X-ray examination reveals a solitary nodule or mass in the lungs, with spicules,

[0039] 2. People with high-risk lungs, cough or bloody sputum, localized lesions found in chest X-ray examination, active anti-inflammatory or anti-tuberculosis treatment (2-4 weeks) is ineffective or the lesions are enlarged,

[0040] 3. Segmental pneumonia develops into lobar atelectasis within 2-3 months, or atelectasis of lung lobe develops into whole lung atelectasis in a short period of time,

[0041] 4. In the short term, there is no other reason for the growth of bloody pleural effusion on one side, or a large amount of bloody pleural effusion on one side accompanied by atelectasis or nodular changes in the pleura,

[0042] 5. Obvious cough, shortness of breath, chest X-ray showing miliary or diffuse lesions in both lungs, miliary ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug for relieving side reactions of targeted therapy and assisting in treatment of lung cancer. The drug is prepared from components as follows: ganoderma lucidum, radix ginseng, herb of sessile skullcap, sweet clover, all grass of gentian apiata, radix jasmini giraldii, allium victorialis, anaphalis lacteal, cane shoots, semen trigonellae, saussurea pulchra, insingnis pulicaria, rubus amphidasys, radix glycyrrhizae, raw radix astragalis, honeysuckle stems, herba patriniae, fructus trichosanthis, radix scutellariae, sweet almond, semen lepidii, dried tangerine peelsand 10-20 Chinese red dates. The provided treatment drug is prepared from pure traditional Chinese medicines, keeps the characteristics of small toxicity and good curative efficacy of natural medicines, has definite curative efficacy and can effectively relieve the side reactions of the targeted therapy. The ganoderma lucidum and the radix ginseng have a certain auxiliary promoting function on rehabilitation from lung cancer and no side effects are produced.

Description

technical field [0001] The invention belongs to the technical field of medical science, and in particular relates to a medicine for alleviating side effects of targeted therapy and assisting the treatment of lung cancer. Background technique [0002] With the development of society and the acceleration of urbanization, people's life has become very convenient, but the living environment has been seriously affected. Air pollution, food pollution, water pollution and other serious threats to people's health, coupled with smoking And other bad living habits, more and more people have changed to lung cancer. Due to the fastest growing incidence and mortality of lung cancer, it has become one of the malignant tumors that threaten the health and life of the population. In the past 50 years, many countries have reported that the morbidity and mortality of lung cancer have increased significantly, and the morbidity and mortality of male lung cancer account for the first of all malig...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/899A61P11/00A61P35/00
CPCA61K36/074A61K36/258A61K36/28A61K36/285A61K36/31A61K36/355A61K36/428A61K36/48A61K36/481A61K36/484A61K36/515A61K36/539A61K36/63A61K36/725A61K36/73A61K36/736A61K36/752A61K36/84A61K36/8962A61K36/899A61K2236/331A61K2300/00
Inventor 于燕霞李淑英
Owner SHANDONG UNIV QILU HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com